A neuroimaging study conducted in the United Kingdom found that taking the antipsychotic amisulpride (400 mg/day) for one ...

In a previous article, I made the case that little has changed within the antipsychotic drug landscape over the past 70 years since the only effective medications for the treatment of schizophrenia ...

Haloperidol is an antipsychotic drug commonly used to treat a range of neurological disorders, including schizophrenia, Tourette syndrome, bipolar disorder and others. The drug works by blocking ...

Antipsychotic use is linked to increased glucose and insulin levels in patients with severe mental illness regardless of dose or weight changes, a new meta-analysis shows.

New research indicates that individuals living with dementia are being treated with potent antipsychotic medications for ...

In September 2025, The FDA approved an injectable extended-release risperidone suspension from Amneal Pharmaceuticals, ...

A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Md. automation The U.S. Food and Drug Administration (FDA) on Thursday approved the first ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on ...

Semaglutide is linked to significant weight loss and glucose levels in adults with schizophrenia, overweight/obesity, and ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb, combines ...